Drug General Information (ID: D1593)
  Drug Name
Tirofiban
  Drug Type Small molecule
  Drug Synonymous
AGG; Aggrastat; Agrastat; Tirofibanum; Aggrastat (TN); Agrastat (TN); L-700462; MK-383; Tirofiban (INN); Tirofiban[BAN:INN]; Tirofiban [INN:BAN]; L-700,462; N-(BUTYLSULFONYL)-O-[4-(4-PIPERIDINYL)BUTYL]-L-TYROSINE; N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine; N-(butylsulfonyl)-O-(4-piperidin-4-ylbutyl)-L-tyrosine; N-(butylsulfonyl)-o-[4-(piperidin-4-yl)butyl]-l-tyrosine; (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid
    Click to Show/Hide
  Disease Class BA41-BA43: Myocardial infarction
  Therapeutic Class Fibrinolytic Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C22H36N2O5S
  InChI 1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1
  InChIKey COKMIXFXJJXBQG-NRFANRHFSA-N
  Canonical SMILES CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
  External Link
Pubchem ID 60947
CAS Number 144494-65-5
CHEBI ID 9605
TTD ID D0BN9X

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM050  Increased risk of bleeding
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Tirofiban
      Pharmacodynamic additive effects
   Increased risk of bleeding Drug Num:  129
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0005
 
Abciximab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3]
D0047
 
Alteplase
 
NA
 
NA
Major    Inter Info   
[1], [2], [4]
D0084
 
Anagrelide
 
C10H7Cl2N3O
 
135409400 
Major    Inter Info   
[5], [3]
D0088
 
Anistreplase
 
NA
 
NA
Major    Inter Info   
[1], [2], [4]
D0102
 
Ardeparin
 
C26H42N2O37S5
 
772 
Major    Inter Info   
[6], [7], [8], [9], [10], [11], [12]
D0104
 
Argatroban
 
C23H36N6O5S
 
92722 
Major    Inter Info   
[13], [14], [15]
D0364
 
Clopidogrel
 
C16H16ClNO2S
 
60606 
Major    Inter Info   
[16], [5], [3], [17]
D0481
 
Dicoumarol
 
C19H12O6
 
54676038 
Major    Inter Info   
[18], [5], [3]
D0537
 
Drotrecogin alfa
 
NA
 
NA
Major    Inter Info   
[19]
D0588
 
Eptifibatide
 
C35H49N11O9S2
 
448812 
Major    Inter Info   
[1], [2], [3]
D0690
 
Fondaparinux
 
C31H53N3O49S8
 
5282448 
Major    Inter Info   
[6], [7], [8], [9], [10], [11], [12]
D0784
 
Ibritumomab tiuxetan
 
NA
 
NA
Major    Inter Info   
[20]
D0904
 
Lepirudin
 
C287H440N80O111S6
 
118856773 
Major    Inter Info   
[13], [14], [15]
D1395
 
Reteplase
 
NA
 
NA
Major    Inter Info   
[1], [2], [4]
D1506
 
Streptokinase
 
C11H19NO2
 
9815560 
Major    Inter Info   
[1], [2], [4]
D1550
 
Tenecteplase
 
NA
 
NA
Major    Inter Info   
[1], [2], [4]
D1581
 
Ticlopidine
 
C14H14ClNS
 
5472 
Major    Inter Info   
[16], [5], [3], [17]
D0008
 
Acalabrutinib
 
C26H23N7O2
 
71226662 
Major    Inter Info   
[21]
D0087
 
Anisindione
 
C16H12O3
 
2197 
Major    Inter Info   
[5], [3]
D0096
 
Apixaban
 
C25H25N5O4
 
10182969 
Major    Inter Info   
[2], [22]
D0129
 
Avapritinib
 
C26H27FN10
 
118023034 
Major    Inter Info   
[2], [23]
D0176
 
Betrixaban
 
C23H22ClN5O3
 
10275777 
Major    Inter Info   
[24]
D0230
 
Cabozantinib
 
C28H24FN3O5
 
25102847 
Major    Inter Info   
[25]
D0247
 
Cangrelor
 
C17H25Cl2F3N5O12P3S2
 
9854012 
Major    Inter Info   
[2], [26]
D0250
 
Caplacizumab
 
NA
 
NA
Major    Inter Info   
[1], [2], [27]
D0414
 
Dalteparin
 
C26H42N2O37S5
 
772 
Major    Inter Info   
[6], [7], [8], [9], [10], [11], [12]
D0415
 
Danaparoid
 
NA
 
NA
Major    Inter Info   
[6], [7], [8], [9], [10], [11], [12]
D0428
 
Dasatinib
 
C22H26ClN7O2S
 
3062316 
Major    Inter Info   
[28]
D0432
 
Deferasirox
 
C21H15N3O4
 
214348 
Major    Inter Info   
[29], [30]
D0435
 
Defibrotide
 
C20H21N4O6P
 
135565962 
Major    Inter Info   
[2], [31]
D0447
 
Desirudin
 
C287H440N80O110S6
 
16129703 
Major    Inter Info   
[32], [33]
D0506
 
Dipyridamole
 
C24H40N8O4
 
3108 
Major    Inter Info   
[16], [5], [3], [17]
D0551
 
Edoxaban
 
C24H30ClN7O4S
 
10280735 
Major    Inter Info   
[34]
D0574
 
Enoxaparin
 
C26H42N2O37S5
 
772 
Major    Inter Info   
[6], [7], [8], [9], [10], [11], [12]
D0753
 
Heparin
 
C26H42N2O37S5
 
772 
Major    Inter Info   
[35], [36], [37], [38], [39], [5], [3], [40]
D0785
 
Ibrutinib
 
C25H24N6O2
 
24821094 
Major    Inter Info   
[41], [42], [2], [43]
D0805
 
Inotersen
 
C230H318N69O121P19S19
 
121492004 
Major    Inter Info   
[2], [29], [44]
D1174
 
Omacetaxine mepesuccinate
 
C29H39NO9
 
285033 
Major    Inter Info   
[29], [45]
D1221
 
Panobinostat
 
C21H23N3O2
 
6918837 
Major    Inter Info   
[1], [2], [46]
D1313
 
Ponatinib
 
C29H27F3N6O
 
24826799 
Major    Inter Info   
[47]
D1328
 
Prasugrel
 
C20H20FNO3S
 
6918456 
Major    Inter Info   
[16], [5], [3], [17]
D1380
 
Ramucirumab
 
NA
 
NA
Major    Inter Info   
[48]
D1387
 
Regorafenib
 
C21H15ClF4N4O3
 
11167602 
Major    Inter Info   
[2], [49], [50]
D1417
 
Rivaroxaban
 
C19H18ClN3O5S
 
9875401 
Major    Inter Info   
[51]
D1588
 
Tinzaparin
 
C26H42N2O37S5
 
772 
Major    Inter Info   
[6], [7], [8], [9], [10], [11], [12]
D1592
 
Tipranavir
 
C31H33F3N2O5S
 
54682461 
Major    Inter Info   
[52]
D1623
 
Trastuzumab emtansine
 
NA
 
NA
Major    Inter Info   
[1], [2], [53]
D1705
 
Vorapaxar
 
C29H33FN2O4
 
10077130 
Major    Inter Info   
[54]
D1718
 
Zanubrutinib
 
C27H29N5O3
 
135565884 
Major    Inter Info   
[29]
D1613
 
Tositumomab
 
NA
 
NA
Major    Inter Info   
[55], [56]
D1614
 
Tositumomab (I-131)
 
NA
 
NA
Major    Inter Info   
[55], [56]
D1669
 
Urokinase
 
NA
 
NA
Major    Inter Info   
[1], [2], [4]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Major    Inter Info   
[5], [3]
D0189
 
Bivalirudin
 
C98H138N24O33
 
16129704 
Moderate    Inter Info   
[14]
D0298
 
Celecoxib
 
C17H14F3N3O2S
 
2662 
Moderate    Inter Info   
[57]
D0345
 
Citalopram
 
C20H21FN2O
 
2771 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0384
 
Collagenase clostridium histolyticum
 
NA
 
NA
Moderate    Inter Info   
[96]
D0476
 
Diclofenac
 
C14H11Cl2NO2
 
3033 
Moderate    Inter Info   
[5], [3]
D0477
 
Diclofenac (ophthalmic)
 
C14H11Cl2NO2
 
3033 
Moderate    Inter Info   
[97], [98], [99]
D0478
 
Diclofenac (topical)
 
C14H11Cl2NO2
 
3033 
Moderate    Inter Info   
[97], [98], [99]
D0539
 
Duloxetine
 
C18H19NOS
 
60835 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0624
 
Etodolac
 
C17H21NO3
 
3308 
Moderate    Inter Info   
[5], [3]
D0641
 
Fenfluramine
 
C12H16F3N
 
3337 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0645
 
Fenoprofen
 
C15H14O3
 
3342 
Moderate    Inter Info   
[5], [3]
D0676
 
Fluoxetine
 
C17H18F3NO
 
3386 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0680
 
Flurbiprofen
 
C15H13FO2
 
3394 
Moderate    Inter Info   
[5], [3]
D0681
 
Flurbiprofen (ophthalmic)
 
C15H13FO2
 
3394 
Moderate    Inter Info   
[97], [98], [99]
D0687
 
Fluvoxamine
 
C15H21F3N2O2
 
5324346 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1815
 
Icosapent
 
C20H30O2
 
446284 
Moderate    Inter Info   
[2], [100], [101]
D0800
 
Indomethacin
 
C19H16ClNO4
 
3715 
Moderate    Inter Info   
[5], [3]
D0882
 
Ketorolac
 
C15H13NO3
 
3826 
Moderate    Inter Info   
[5], [3]
D0883
 
Ketorolac (ophthalmic)
 
C15H13NO3
 
3826 
Moderate    Inter Info   
[97], [98], [99]
D1097
 
Nabumetone
 
C15H16O2
 
4409 
Moderate    Inter Info   
[5], [3]
D1229
 
Paroxetine
 
C19H20FNO3
 
43815 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1249
 
Pentosan polysulfate
 
C10H18O21S4
 
37720 
Moderate    Inter Info   
[29], [102]
D1300
 
Piroxicam
 
C15H13N3O4S
 
54676228 
Moderate    Inter Info   
[5], [3]
D1421
 
Rofecoxib
 
C17H14O4S
 
5090 
Moderate    Inter Info   
[57]
D1520
 
Sulindac
 
C20H17FO3S
 
1548887 
Moderate    Inter Info   
[5], [3]
D0017
 
Acetylsalicylic acid
 
C9H8O4
 
2244 
Moderate    Inter Info   
[37], [16], [5]
D0187
 
Bismuth subsalicylate
 
C7H6BiO4
 
16682734 
Moderate    Inter Info   
[37], [16], [5], [3]
D0211
 
Bromfenac (ophthalmic)
 
C15H12BrNO3
 
60726 
Moderate    Inter Info   
[97], [98], [99]
D0331
 
Choline salicylate
 
C12H19NO4
 
54686350 
Moderate    Inter Info   
[37], [16], [5], [3]
D0336
 
Cilostazol
 
C20H27N5O2
 
2754 
Moderate    Inter Info   
[103], [104], [105]
D0361
 
Clomipramine
 
C19H23ClN2
 
2801 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1769
 
Deoxycholic acid
 
C24H40O4
 
222528 
Moderate    Inter Info   
[29], [106]
D0451
 
Desvenlafaxine
 
C16H25NO2
 
125017 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0457
 
Dexfenfluramine
 
C12H16F3N
 
66265 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0489
 
Diflunisal
 
C13H8F2O3
 
3059 
Moderate    Inter Info   
[37], [16], [5], [3]
D0586
 
Epoprostenol
 
C20H32O5
 
5282411 
Moderate    Inter Info   
[107], [108], [109]
D0599
 
Escitalopram
 
C20H21FN2O
 
146570 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0711
 
Garlic
 
NA
 
NA
Moderate    Inter Info   
[110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D0721
 
Ginger
 
C30H40O6
 
442138 
Moderate    Inter Info   
[115], [125], [126], [119], [122]
D0722
 
Ginkgo biloba
 
NA
 
NA
Moderate    Inter Info   
[127], [128], [129], [130], [112], [131], [132], [113], [115], [116], [133], [125], [134], [119], [135], [136], [137], [122], [138]
D0723
 
Ginseng
 
C42H66O17
 
420552 
Moderate    Inter Info   
[139], [113], [115], [140], [116], [141], [119], [122], [142]
D0752
 
Hemin
 
C34H32FeN4O4
 
26945 
Moderate    Inter Info   
[143]
D0786
 
Ibuprofen
 
C13H18O2
 
3672 
Moderate    Inter Info   
[5], [3]
D0792
 
Iloprost
 
C22H32O4
 
5311181 
Moderate    Inter Info   
[107], [108], [109]
D0881
 
Ketoprofen
 
C16H14O3
 
3825 
Moderate    Inter Info   
[5], [3]
D0920
 
Levomilnacipran
 
C15H22N2O
 
6917779 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D0988
 
Meclofenamic acid
 
C14H11Cl2NO2
 
4037 
Moderate    Inter Info   
[5], [3]
D0995
 
Meloxicam
 
C14H13N3O4S2
 
54677470 
Moderate    Inter Info   
[5], [3]
D1066
 
Milnacipran
 
C15H22N2O
 
65833 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1109
 
Naproxen
 
C14H14O3
 
156391 
Moderate    Inter Info   
[5], [3]
D1123
 
Nepafenac (ophthalmic)
 
C15H14N2O2
 
151075 
Moderate    Inter Info   
[97], [98], [99]
D1139
 
Nintedanib
 
C31H33N5O4
 
135423438 
Moderate    Inter Info   
[144]
D1140
 
Niraparib
 
C19H20N4O
 
24958200 
Moderate    Inter Info   
[2], [145]
D1178
 
Omega-3 fatty acids
 
C60H92O6
 
56842239 
Moderate    Inter Info   
[2], [100], [101]
D1196
 
Oxaprozin
 
C18H15NO3
 
4614 
Moderate    Inter Info   
[5], [3]
D1251
 
Pentoxifylline
 
C13H18N4O3
 
4740 
Moderate    Inter Info   
[146], [147]
D1272
 
Phenyl salicylate
 
C13H10O3
 
8361 
Moderate    Inter Info   
[37], [16], [5]
D1274
 
Phenylbutazone
 
C19H20N2O2
 
4781 
Moderate    Inter Info   
[5], [3]
D1439
 
Salicylic acid (sodium)
 
C7H6O3
 
338 
Moderate    Inter Info   
[37], [16], [5]
D1442
 
Salsalate
 
C14H10O5
 
5161 
Moderate    Inter Info   
[37], [16], [5], [3]
D1460
 
Selumetinib
 
C17H15BrClFN4O3
 
10127622 
Moderate    Inter Info   
[148], [149], [150]
D1461
 
Sertraline
 
C17H17Cl2N
 
68617 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1464
 
Sibutramine
 
C17H26ClN
 
5210 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1523
 
Suprofen (ophthalmic)
 
C14H12O3S
 
5359 
Moderate    Inter Info   
[97], [98], [99]
D1579
 
Ticagrelor
 
C23H28F2N6O4S
 
9871419 
Moderate    Inter Info   
[2], [151]
D1696
 
Vilazodone
 
C26H27N5O2
 
6918314 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1708
 
Vortioxetine
 
C18H22N2S
 
9966051 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1606
 
Tolmetin
 
C15H15NO3
 
5509 
Moderate    Inter Info   
[5], [3]
D1625
 
Treprostinil
 
C23H34O5
 
6918140 
Moderate    Inter Info   
[107], [108], [109]
D1674
 
Valdecoxib
 
C16H14N2O3S
 
119607 
Moderate    Inter Info   
[57]
D1689
 
Venlafaxine
 
C17H27NO2
 
5656 
Moderate    Inter Info   
[58], [59], [60], [61], [1], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95]
D1703
 
Vitamin E
 
C29H50O2
 
14985 
Moderate    Inter Info   
[148], [154], [2], [155], [156], [157], [158], [115], [159], [160], [161], [162], [163], [164], [165], [149], [166], [167], [150], [168]
D0253
 
Capsicum
 
NA
 
NA
Minor    Inter Info   
[115]
D0309
 
Chamomile
 
C15H10O5
 
5280443 
Minor    Inter Info   
[115], [169], [119]
D0368
 
Clove
 
NA
 
NA
Minor    Inter Info   
[115], [170], [171], [172]
D1661
 
Turmeric
 
C21H20O6
 
969516 
Minor    Inter Info   
[173], [115], [174]
      Pharmacodynamic antagonistic effects
   Attenuated pharmacological effects (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1691
 
Verteporfin
 
C82H84N8O16
 
11980904 
Moderate    Inter Info   
[152], [153]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. ReoPro (abciximab). Lilly, Eli and Company, Indianapolis, IN.
4 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA."
5 Product Information. Integrilin (eptifibatide). Schering Laboratories, Kenilworth, NJ.
6 Price AJ, Frcpath DO "Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?" Ann R Coll Surg Engl 77 (1995): 395. [PMID: 7486773]
7 Product Information. Arixtra (fondaparinux). Organon, West Orange, NJ.
8 Product Information. Fragmin (dalteparin). Pharmacia and Upjohn, Kalamazoo, MI.
9 Product Information. Innohep (tinzaparin) DuPont Pharmaceuticals, Wilmington, DE.
10 Product Information. Lovenox (enoxaparin). Rhone-Poulenc Rorer, Collegeville, PA.
11 Product Information. Normiflo (ardeparin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
12 Product Information. Orgaran (danaparoid). Organon, West Orange, NJ.
13 Product Information. Acova (argatroban) SmithKline Beecham, Philadelphia, PA.
14 Product Information. Angiomax (bivalirudin) The Medicines Compny, Cambridge, MA.
15 Product Information. Refludan (lepirudin). Hoechst Marion-Roussel Inc, Kansas City, MO.
16 Klinkhardt U, Kirchmaier CM, Westrup D, Graff J, Mahnel R, Breddin HK, Harder S "Ex vivo-in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A." Clin Pharmacol Ther 67 (2000): 305-13. [PMID: 10741635]
17 O'Donoghue M, Antman EM, Braunwald E, et al. "The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Pla" J Am Coll Cardiol 54 (2009): 678-85. [PMID: 19679245]
18 Guo LQ, Yamazoe Y "Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines." Acta Pharmacol Sin 25 (2004): 129-36. [PMID: 14769198]
19 Product Information. Xigris (drotrecogin alfa). Lilly, Eli and Company, Indianapolis, IN.
20 Product Information. In-111 Zevalin (ibritumomab). IDEC Pharmaceuticals Corporation, San Diego, CA.
21 Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
22 Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
23 Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
24 Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
25 Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
26 Product Information. Kengreal (cangrelor). The Medicines Company, Parsippany, NJ.
27 Product Information. Cablivi (caplacizumab). Genzyme Corporation, Cambridge, MA.
28 Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
29 Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
30 Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
31 Product Information. Defitelio (defibrotide). Jazz Pharmaceuticals, Palo Alto, CA.
32 Product Information. Ipravask (desirudin). Aventis Pharmaceuticals, Swiftwater, PA.
33 Product Information. Pradaxa (dabigatran). Boehringer-Ingelheim, Ridgefield, CT.
34 Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
35 Adderhuis KM, Deckers JW, Lincoff AM, et al. "Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention." JAMA 286 (2001): 78-82. [PMID: 11434830]
36 Blankenship JC "Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors." Am Heart J 138 (1999): s287-96. [PMID: 10502234]
37 Hirsch J, Dalen J, Guyatt G, American College of Chest Physicians "The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Physicians." Chest 119(1 Suppl) (2001): 1S-2S. [PMID: 11157638]
38 Juran NB "Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy." Am Heart J 138 (1999): s297-306. [PMID: 10502235]
39 Product Information. Aggrastat (tirofiban). Merck & Co, Inc, West Point, PA.
40 Caillard S, Leray C, Kunz K, Gachet C, Offner M, Wiesel ML, Hannedouchte T, Cazenave JP, Moulin B "Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients." Transplant Proc 32 (2000): 2787-8. [PMID: 11134806]
41 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
42 Cerner Multum, Inc. "Canadian Product Information.".
43 Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
44 Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
45 Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
46 Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
47 Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
48 Product Information. Cyramza (ramucirumab). Eli Lilly and Company, Indianapolis, IN.
49 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
50 Product Information. Stivarga (regorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
51 Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
52 Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
53 Product Information. Kadcyla (ado-trastuzumab). Genentech, South San Francisco, CA.
54 Product Information. Zontivity (vorapaxar). Merck & Company Inc, Whitehouse Station, NJ.
55 Product Information. Bexxar I 131 Therapeutic (iodine I 131 tositumomab). GlaxoSmithKline, Research Triangle Park, NC.
56 Product Information. BexxarTherapy (tositumomab). GlaxoSmithKline Inc, Oakville, IA.
57 Product Information. Celebrex (celecoxib). Searle, Chicago, IL.
58 Alderman CP, Moritz CK, Ben-Tovim DI "Abnormal platelet aggregation associated with fluoxetine therapy." Ann Pharmacother 26 (1992): 1517-9. [PMID: 1482806]
59 Alderman CP, Seshadri P, Ben-Tovim DI "Effects of serotonin reuptake inhibitors on hemostasis." Ann Pharmacother 30 (1996): 1232-4. [PMID: 8913401]
60 Aranth J, Lindberg C "Bleeding, a side effect of fluoxetine." Am J Psychiatry 149 (1992): 412. [PMID: 1536285]
61 Bannister SJ, Houser VP, Hulse JD, Kisicki JC, Rasmussen JG "Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin." Acta Psychiatr Scand Suppl 350 (1989): 102-6. [PMID: 2530759]
62 Ciraulo DA, Shader RI "Fluoxetine drug-drug interactions. II." J Clin Psychopharmacol 10 (1990): 213-7. [PMID: 2198298]
63 Claire RJ, Servis ME, Cram DL Jr "Potential interaction between warfarin sodium and fluoxetine." Am J Psychiatry 148 (1991): 1604. [PMID: 1928485]
64 Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH "Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study." Arch Intern Med 163 (2003): 59-64. [PMID: 12523917]
65 de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S "Intracranial haemorrhage and use of selective serotonin reuptake inhibitors." Br J Clin Pharmacol 50 (2000): 43-7. [PMID: 10886117]
66 de Abajo FJ, Rodriguez LA, Montero D "Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study." BMJ 319 (1999): 1106-9. [PMID: 10531103]
67 de Maistre E, Allart C, Lecompte T, Bollaert PE "Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors." Am J Med 113 (2002): 530-2. [PMID: 12427509]
68 Dent LA, Orrock MW "Warfarin-fluoxetine and diazepam-fluoxetine interaction." Pharmacotherapy 17 (1997): 170-2. [PMID: 9017779]
69 Ford MA, Anderson ML, Rindone JP, Jaskar DW "Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin." J Clin Psychopharmacol 17 (1997): 110-2. [PMID: 10950474]
70 Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B "Paroxetine decreases platelet serotonin storage and platelet function in human beings." Clin Pharmacol Ther 68 (2000): 435-42. [PMID: 11061584]
71 Humphries JE, Wheby MS, VandenBerg SR "Fluoxetine and the bleeding time." Arch Pathol Lab Med 114 (1990): 727-8. [PMID: 2363631]
72 Krivy J, Wiener J "Sertraline and platelet counts in idiopathic thrombocytopenia purpura." Lancet 345 (1995): 132. [PMID: 7815874]
73 Leung M, Shore R "Fluvoxamine-associated bleeding." Can J Psychiatry 41 (1996): 604-5. [PMID: 8946088]
74 Messiha FS "Fluoxetine - adverse effects and drug-drug interactions." J Toxicol Clin Toxicol 31 (1993): 603-30. [PMID: 8254702]
75 Ottervanger JP, Stricker BH, Huls J, Weeda JN "Bleeding attributed to the intake of paroxetine." Am J Psychiatry 151 (1994): 781-2. [PMID: 8166328]
76 Pai VB, Kelly MW "Bruising associated with the use of fluoxetine." Ann Pharmacother 30 (1996): 786-8. [PMID: 8826562]
77 Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
78 Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
79 Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
80 Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
81 Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
82 Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
83 Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
84 Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
85 Product Information. Pristiq (desvenlafaxine). Wyeth Laboratories, Philadelphia, PA.
86 Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
87 Product Information. Savella (milnacipran). Forest Pharmaceuticals, St. Louis, MO.
88 Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
89 Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
90 Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
91 Skop BP, Brown TM "Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors." Psychosomatics 37 (1996): 12-6. [PMID: 8600488]
92 Woolfrey S, Gammack NS, Dewar MS, Brown PJ "Fluoxetine-warfarin interaction." BMJ 307 (1993): 241. [PMID: 8369688]
93 Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ "Fluoxetine and bleeding in obsessive-compulsive disorder." Am J Psychiatry 148 (1991): 949. [PMID: 2053641]
94 Layton D, Clark DWJ, Pearce GL, Shakir SAW "Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England." Eur J Clin Pharmacol 57 (2001): 167-76. [PMID: 11417450]
95 Tata LJ, Fortun PJ, Hubbard RB, et al. "Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?" Aliment Pharmacol Ther 22 (2005): 175-81. [PMID: 16091054]
96 Product Information. Xiaflex (collagenase clostridium histolyticum). Auxilium Pharmaceuticals Inc, Norristown, PA.
97 Product Information. Acular (ketorolac). Allergan Inc, Irvine, CA.
98 Product Information. Nevanac (nepafenac ophthalmic). Alcon Laboratories Inc, Fort Worth, TX.
99 Product Information. Xibrom (bromfenac ophthalmic). ISTA Pharmaceuticals, Irvine, CA.
100 Li XL, Steiner M "Fish oil: a potent inhibitor of platelet adhesiveness." Blood 76 (1990): 938-45. [PMID: 2118400]
101 Product Information. Vascepa (icosapent). Amarin Pharmaceuticals Inc, Warren, NJ.
102 Product Information. Elmiron (pentosan polysulfate sodium). Baker Norton Pharmaceuticals, Miami, FL.
103 Product Information. Pletal (cilostazol). Otsuka American Pharmaceuticals, Rockville, MD.
104 Wilhite DB, Comerota AJ, Schmieder FA, Throm RC, Gaughan JP, Rao AK "Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time." J Vasc Surg 38 (2003): 710-3
105 Mallikaarjun S, Forbes WP, Bramer SL "Interaction potential and tolerability of the coadministration of cilostazol and aspirin." Clin Pharmacokinet 37 (1999): 87-93
106 Product Information. Kybella (deoxycholic acid). Kythera Biopharmaceuticals, Inc., Westlake Village, CA.
107 Product Information. Flolan (epoprostenol). Glaxo Wellcome, Research Triangle Park, NC.
108 Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
109 Product Information. Ventavis (iloprost). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
110 Burnham BE "Garlic as a possible risk for postoperative bleeding." Plast Reconstr Surg 95 (1995): 213. [PMID: 7809259]
111 Chutani SK, Bordia A "The effect of fried versus raw garlic on fibrinolytic activity in man." Atherosclerosis 38 (1981): 417-21. [PMID: 7225179]
112 Evans V "Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use." J Neurosci Nurs 32 (2000): 229-32. [PMID: 10994537]
113 Fugh-Berman A "Herb-drug interactions." Lancet 355 (2000): 134-8. [PMID: 10675182]
114 German K, Kumar U, Blackford HN "Garlic and the risk of TURP bleeding." Br J Urol 76 (1996): 518. [PMID: 7551902]
115 Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
116 Izzo AA, Ernst E "Interactions between herbal medicines and prescribed drugs: a systematic review." Drugs 61 (2001): 2163-75. [PMID: 11772128]
117 Kiesewetter H, Jung F, Jung EM, Mrowietz C, Kosciehlny J, Wenzel E "Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack." Eur J Clin Pharmacol 45 (1993): 333-6. [PMID: 8299665]
118 Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S "Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects." Arzneimittelforschung 43 (1993): 119-22. [PMID: 8457236]
119 Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
120 Morris J, Burke V, Mori TA, Vandongen R, Beilin LJ "Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study." Clin Exp Pharmacol Physiol 22 (1995): 414-7. [PMID: 8582091]
121 Steiner M, Lin RS "Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract." J Cardiovasc Pharmacol 31 (1998): 904-8. [PMID: 9641475]
122 Vaes LP, Chyka PA "Interactions of warfarin with garlic, ginger, or ginseng: nature of evidence." Ann Pharmacother 34 (2000): 1478-82. [PMID: 11144706]
123 Apitz-Castro R, Escalante J, Vargas R, Jain MK "Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets." Thromb Res 42 (1986): 303-11. [PMID: 3520940]
124 Mulrow C, Lawrence V, Ackermann R, et al. Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects.?Evid Rep Technol Assess (Summ). 2000;(20):1-4. [PMID: 11089496]
125 Jiang X, Williams KM, Liauw WS, et al. "Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects." Br J Clin Pharmacol 59 (2005): 425-32. [PMID: 15801937]
126 Kruth P, Brosi E, Fux R, Morike K, Gleiter CH "Ginger-associated overanticoagulation by phenprocoumon." Ann Pharmacother 38 (2004): 257-60. [PMID: 14742762]
127 Benjamin J, Muir T, Briggs K, Pentland B "A case of cerebral haemorrhage - can Ginkgo biloba be implicated?." Postgrad Med J 77 (2001): 112-3. [PMID: 11161079]
128 Chung KF, McCusker M, Page CP, Dent G, Guinot P, Barnes PJ "Effect of ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet acitivating factor in man." Lancet 1 (1987): 248-51. [PMID: 2880069]
129 Cupp MJ "Herbal remedies: adverse effects and drug interactions." Am Fam Physician 59 (1999): 1239-45. [PMID: 10088878]
130 Engelsen J, Nielsen JD, Winther K "Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial." Thromb Haemost 87 (2002): 1075-6. [PMID: 12083489]
131 Fessenden JM, Wittenborn W, Clarke L "Gingko biloba: A case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy." Am Surg 67 (2001): 33-5. [PMID: 11206893]
132 Fong KC, Kinnear PE "Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion." Postgrad Med J 79 (2003): 531-2. [PMID: 13679551]
133 Jayasekera N, Moghal A, Kashif F, Karalliedde L "Herbal medicines and postoperative haemorrhage." Anaesthesia 60 (2005): 725-6. [PMID: 15960738]
134 Matthews MK Jr "Association of Ginko biloba with intracerebral hemorrhage." Neurology 50 (1998): 1933-4. [PMID: 9633781]
135 Rosenblatt M, Mindel J "Spontaneous hyphema associated with ingestion of Ginkgo biloba extract." N Engl J Med 336 (1997): 1108. [PMID: 9091822]
136 Rowin J, Lewis SL "Spontaneous bilateral subdural hematomas associated with chronic Gingko biloba ingestion." Neurology 46 (1996): 1775-6. [PMID: 8649594]
137 Sierpina VS, Wollschlaeger B, Blumenthal M "Ginkgo biloba." Am Fam Physician 68 (2003): 923-6. [PMID: 13678141]
138 Wolf HR "Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?" Drugs R D 7 (2006): 163-72. [PMID: 16752942]
139 Ang-Lee MK, Moss J, Yuan CS "Herbal medicines and perioperative care." JAMA 286 (2001): 208-16. [PMID: 11448284]
140 Hodges PJ, Kam PC "The peri-operative implications of herbal medicines." Anaesthesia 57 (2002): 889-99. [PMID: 12190754]
141 Janetzky K, Morreale AP "Probable interaction between warfarin and ginseng." Am J Health Syst Pharm 54 (1997): 692-3. [PMID: 9075501]
142 Yuan CS, Wei G, Dey L, et al. "Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial." Ann Intern Med 141 (2004): 23-7. [PMID: 15238367]
143 Product Information. Panhematin (hemin). Recordati Rare Diseases Inc, Lebanon, NJ.
144 Product Information. Ofev (nintedanib). Boehringer Ingelheim, Ridgefield, CT.
145 Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
146 Canadian Pharmacists Association.
147 Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
148 Booth SL, Golly I, Sacheck JM, Roubenoff R, Dallal GE, et al "Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status." Am J Clin Nutr 80 (2004): 143-8. [PMID: 15213041]
149 Murohara T, Ikeda H, Otsuka Y, Aoki M, Takajo Y, et al "Inhibition of platelet adherence to Mononuclear cells by alpha-tocopherol: role of P-selection." Circulation 110 (2004): 141-8. [PMID: 15197142]
150 Vitamin K, vitamin E and the coumarin drugs. Nutr Rev 40 (1982): 180-2. [PMID: 7121898]
151 Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
152 Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
153 Product Information. Xatral (alfuzosin). Sanofi-Synthelabo Canada Inc, Markham, ON.
154 Celestini A, Pulcinelli FM, Pignatelli P, et al. "Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets." Haematologica 87 (2002): 420-6. [PMID: 11940487]
155 Corrigan JJ "The effect of vitamin E on warfarin-induced vitamin K deficiency." Ann N Y Acad Sci 393 (1982): 361-8. [PMID: 6959563]
156 Corrigan JJ, Ulfers LL "Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency." Am J Clin Nutr 34 (1981): 1701-5. [PMID: 7282596]
157 Freedman JE, Farhat JH, Loscalzo J, Keaney JF "Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C--dependent mechanism." Circulation 94 (1996): 2434-40. [PMID: 8921785]
158 Gonzalez-Correa JA, Arrebola MM, Guerrero A, et al. "Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood." Platelets 16(3-4) (2005): 171-9. [PMID: 16011961]
159 Helson L "The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors." Thromb Res 35 (1984): 11-8. [PMID: 6474408]
160 Jandak J, Steiner M, Richardson PD "Alpha-tocopherol, an effective inhibitor of platelet adhesion." Blood 73 (1989): 141-9. [PMID: 2910355]
161 Kakishita E, Suehiro A, Oura Y, Nagai K "Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood." Thromb Res 60 (1990): 489-99. [PMID: 2082481]
162 Kim JM, White RH "Effect of vitamin E on the anticoagulant response to warfarin." Am J Cardiol 77 (1996): 545-6. [PMID: 8629604]
163 Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T "Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms." Am J Clin Nutr 77 (2003): 700-6. [PMID: 12600864]
164 Mardla V, Kobzar G, Samel N "Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin." Platelets 15 (2004): 319-24. [PMID: 15370103]
165 Megavitamin E supplementation and vitamin K-dependent carboxylation. Nutr Rev 41 (1983): 268-70. [PMID: 6358960]
166 Schrogie JJ "Coagulopathy and fat-soluble vitamins." JAMA 232 (1975): 19. [PMID: 1172961]
167 Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D "Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels." Am J Clin Nutr 47 (1988): 700-6. [PMID: 3128100]
168 Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C "Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis." Pharmacotherapy 27 (2007): 1237-47. [PMID: 17723077]
169 Lambert JP, Cormier J "Potential interaction between warfarin and boldo-fenugreek." Pharmacotherapy 21 (2001): 509-12. [PMID: 11310527]
170 Saeed SA, Gilani AH "Antithrombotic activity of clove oil." J Pak Med Assoc 44 (1994): 112-5. [PMID: 8078176]
171 Srivasta KC "Antiplatelet principles from a food spice clove (Syzygium aromaticum L) [corrected]" Prostaglandins Leukot Essent Fatty Acids 48 (1993): 363-72. [PMID: 8321872]
172 Srivstava KC, Malhotra N "Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets." Prostaglandins Leukot Essent Fatty Acids 42 (1991): 73-81. [PMID: 2011614]
173 Abebe W "Herbal medication: potential for adverse interactions with analgesic drugs." J Clin Pharm Ther 27 (2002): 391-401. [PMID: 12472978]
174 Yang X, Thomas DP, Zhang X, et al "Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation." Arterioscler Thromb Vasc Biol 26 (2006): 85-90. [PMID: 16239599]